首页> 美国卫生研究院文献>Journal of Surgical Case Reports >Mitral valve replacement for Libman–Sacks endocarditis in a patient with antiphospholipid syndrome secondary to systemic lupus erythematosus
【2h】

Mitral valve replacement for Libman–Sacks endocarditis in a patient with antiphospholipid syndrome secondary to systemic lupus erythematosus

机译:系统性红斑狼疮继发抗磷脂综合征患者的二尖瓣置换术治疗Libman-Sacks心内膜炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Libman–Sacks endocarditis is a relatively rare sterile verrucous vegetative lesion observed in systemic lupus erythematosus (SLE)/antiphospholipid syndrome (APLS) patients. Most patients with this condition are asymptomatic. Here we report a case of a 46-year-old woman with APLS secondary to SLE complicated with frequent thromboembolic events due to a mitral valve mass. We performed minimally invasive mitral valve replacement with a mechanical prosthetic valve, and she was successfully discharged 14 days after surgery. Thus, Libman–Sacks endocarditis may be an indication for mitral valve replacement.
机译:Libman-Sacks心内膜炎是在系统性红斑狼疮(SLE)/抗磷脂综合征(APLS)患者中观察到的相对罕见的无菌疣状营养性病变。大多数患有此病的患者无症状。在这里,我们报道一例46岁女性,继发于SLE的APLS并由于二尖瓣占位而引起频繁的血栓栓塞事件。我们用机械人工瓣膜进行了微创二尖瓣置换术,术后14天她成功出院。因此,Libman-Sacks心内膜炎可能是二尖瓣置换的指征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号